
MECHANISTIC DRUG SAFETY INTELLIGENCE PLATFORM Cytocast is a TechBio company developing the CYTOCAST DIGITAL TWIN Platform™ for mechanistic drug safety prediction. We help pharmaceutical teams identify and understand side-effect risks early—before costly late-stage failure—by modeling how compounds perturb targets, pathways, and human tissues. INDUSTRY CONTEXT The pharmaceutical industry is transitioning from empirical safety assessment toward mechanistic, model-based approaches. Cytocast is part of this shift—enabling earlier, more predictive safety evaluation aligned with emerging new…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.